Home  >  Products  >  Mafg (v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) ) Blocking Peptide (the N terminal of Mafg)(100ug)
Mafg (v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) ) Blocking Peptide (the N terminal of Mafg)(100ug)

Mafg (v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) ) Blocking Peptide (the N terminal of Mafg)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Mafg Antibody (ARP32010_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP32010
Size: 100ug
Weight: 18kDa
Gene: 17134
Format: Lyophilized powder
Target: Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves. However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins and recruiting them to specific DNA-binding sites. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Transcription factor, component of erythroid-specific transcription factor NF-E2. Mafg activates globin gene expression when associated with NF-E2 and may be involved in signal transduction of extracellular H+.
Alternative names: AA545192; C630022N07Rik
See Full Product Listings >